ArticleDiagnostics (Basel, Switzerland)2023
ETISTP: An Enhanced Model for Brain Tumor Identification and Survival Time Prediction.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 17 citations in OpenAlex.
- EDISP: a hybrid CNN-ViT framework for robust maize leaf disease detection and classification.Frontiers in plant science · 2026Article
- A Radiomic Model for Gliomas Grade and Patient Survival Prediction.Bioengineering (Basel, Switzerland) · 2025Article
- Integrative hybrid deep learning for enhanced breast cancer diagnosis: leveraging the Wisconsin Breast Cancer Database and the CBIS-DDSM dataset.Scientific reports · 2024Article
- Enhancing Automated Brain Tumor Detection Accuracy Using Artificial Intelligence Approaches for Healthcare Environments.Bioengineering (Basel, Switzerland) · 2024Article
- Survival Prediction of Patients after Heart Attack and Breast Cancer Surgery with a Hybrid Model Built with Particle Swarm Optimization, Stacked AutoEncoders, and the Softmax Classifier.Biomimetics (Basel, Switzerland) · 2024Article
- Advances in the Use of Deep Learning for the Analysis of Magnetic Resonance Image in Neuro-Oncology.Cancers · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Technology-assisted diagnosis is increasingly important in healthcare systems. Brain tumors are a leading cause of death worldwide, and treatment plans rely heavily on accurate survival predictions. Gliomas, a type of brain tumor, have particularly high mortality rates and can be further classified as low- or high-grade, making survival prediction challenging. Existing literature provides several survival prediction models that use different parameters, such as patient age, gross total resection status, tumor size, or tumor grade. However, accuracy is often lacking in these models. The use of tumor volume instead of size may improve the accuracy of survival prediction. In response to this need, we propose a novel model, the enhanced brain tumor identification and survival time prediction (ETISTP), which computes tumor volume, classifies it into low- or high-grade glioma, and predicts survival time with greater accuracy. The ETISTP model integrates four parameters: patient age, survival days, gross total resection (GTR) status, and tumor volume. Notably, ETISTP is the first model to employ tumor volume for prediction. Furthermore, our model minimizes the computation time by allowing for parallel execution of tumor volume computation and classification. The simulation results demonstrate that ETISTP outperforms prominent survival prediction models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.